Takeda’s TAK-070 for AD Worthy of Clinical Trial: Prof. Iwatsubo of Univ. of Tokyo Hospital

The University of Tokyo Hospital’s Phase I Unit, which will conduct first-in-human (FIH) clinical trials, will conduct its first clinical trial for the Alzheimer’s disease (AD) treatment candidate TAK-070, for which Takeda Pharmaceutical discontinued development in 2004. In a recent...read more